Feedback / Questions
LISPRO (lithium/proline/salicylate) - Alzamend Neuro
https://www.businesswire.com/news/home/20230622197959/en/Alzamend-Neuro-Announces-Positive-Phase-IIA-Clinical-Trial-Results-for-AL001
Jun 22, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next